Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Losartan effective in chronic renal allograft rejection

May 28, 1997

MC-1288 + ciclosporin for allograft rejection

May 26, 1997

Highlights of the 7th INWIN

May 26, 1997

North American Vaccine cleared to initiate trials of meningitis vaccine

May 22, 1997

Malononitrilamides associated with potent immunosuppressive effects in animal models

May 22, 1997

VX-497: selective IMPDH inhibitor with potent immunosuppressive properties

May 22, 1997

PNP inhibitors from Chiroscience for T-cell-mediated disorders

May 21, 1997

Wyeth-Ayerst and NanoSystems agree to develop new formulation of Rapamune

May 20, 1997

Roche and Protein Design Labs report encouraging results from Zenapax trial

May 20, 1997

Phase I/II results for promising compound from BioTransplant and MedImmune

May 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...